Mechanisms Involving Active Chromatin Modification Suppressor Genes in Prostate Cancer Cells by Epigenetic Tumor p 16 INK 4 a and p 21 WAF 1 / CIP 1 Genistein Induces the Updated

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.

  2006cited by this paper
• Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all

  2006cited by this paper
• 5‐Aza‐2′‐deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53‐independent apoptosis in myeloid leukemia

  2005cited by this paper
• Reversal of Hypermethylation and Reactivation of p16INK4a, RARβ, and MGMT Genes by Genistein and Other Isoflavones from Soy

  2005influential reference
• Vitamin D Receptor and p21/WAF1 Are Targets of Genistein and 1,25-Dihydroxyvitamin D3 in Human Prostate Cancer Cells

  2004influential reference
• Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1.

  2004cited by this paper
• Histone modification enzymes: novel targets for cancer drugs.

  2004cited by this paper
• Promoter hypermethylation of the cyclin-dependent kinase inhibitor (CDKI) gene p21WAF1/CIP1/SDI1 is rare in various lymphomas and carcinomas.

  2004cited by this paper
• Methylation of Adjacent CpG Sites Affects Sp1/Sp3 Binding and Activity in the p21Cip1 Promoter

  2003cited by this paper
• Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis.

  2003cited by this paper
• Inhibitory effects of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).

  2003cited by this paper
• MethPrimer: designing primers for methylation PCRs

  2002cited by this paper
• Deacetylase enzymes: biological functions and the use of small-molecule inhibitors.

  2002cited by this paper
• Antiangiogenic and antitumour effects in vivo of genistein applied alone or combined with cyclophosphamide.

  2001cited by this paper
• Transcriptional activation of p21(WAF1/CIP1) by apicidin, a novel histone deacetylase inhibitor.

  2001cited by this paper
• Preclinical and clinical development of cyclin-dependent kinase modulators.

  2000cited by this paper
• Cell cycle checkpoints and their inactivation in human cancer

  2000cited by this paper
• p21CIP1 is dispensable for the G2 arrest caused by genistein in human melanoma cells.

  2000cited by this paper
• Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells.

  2000cited by this paper
• Overexpression of p21waf1 in Human T-Cell Lymphotropic Virus Type 1-Infected Cells and Its Association with Cyclin A/cdk2

  2000cited by this paper
• Low‐dose genistein induces cyclin‐dependent kinase inhibitors and G1 cell‐cycle arrest in human prostate cancer cells

  2000cited by this paper
• Cell-Cycle Control in Mammalian Cells

  2000cited by this paper
• Histone acetylation and cancer.

  1999cited by this paper
• The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review

  1999cited by this paper
• Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein

  1999cited by this paper
• Transforming growth factor-β and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth

  1999cited by this paper
• Attenuation by genistein of sodium‐chloride‐enhanced gastric carcinogenesis induced by N‐methyl‐N′‐nitro‐N‐nitrosoguanidine in Wistar rats

  1999cited by this paper
• Induced Expression of p16INK4a Inhibits Both CDK4- and CDK2-Associated Kinase Activity by Reassortment of Cyclin-CDK-Inhibitor Complexes

  1999cited by this paper
• Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.

  1998cited by this paper
• Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells.

  1998cited by this paper
• Linking histone acetylation to transcriptional regulation

  1998cited by this paper
• Genistein induces p21(Cip1/WAF1) expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells.

  1998cited by this paper
• Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line.

  1998cited by this paper
• Redox-mediated regulation of p21(waf1/cip1) expression involves a post-transcriptional mechanism and activation of the mitogen-activated protein kinase pathway.

  1997cited by this paper
• Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins.

  1995cited by this paper
• 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

  1995cited by this paper
• Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

  1995cited by this paper
• Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells.

  1995cited by this paper
• Functional Analysis of the Transforming Growth Factor βResponsive Elements in the WAF1/Cip1/p21 Promoter (*)

  1995cited by this paper
• How cells cycle toward cancer.

  1994cited by this paper
• Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.

  1994cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

  1993cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• No citing papers are available for this paper.